title: Actionable data analytics in oncology: are we there yet?
abstract: To operate under a new value-based paradigm, oncology providers must develop the capability to aggregate, analyze, measure, and report their value proposition--that is, their outcomes and associated costs. How are oncology providers positioned currently to perform these functions in a manner that is actionable? What is the current state of analytic capabilities in oncology? Are oncology providers prepared? This line of inquiry was the basis for the 2013 Cancer Center Business Summit annual industry research survey. This article reports on the key findings and implications of the 2013 research survey with regard to data analytic capabilities in the oncology sector. The essential finding from the study is that only a small number of oncology providers (7%) currently possess the analytic tools and capabilities necessary to satisfy internal and external demands for aggregating and reporting clinical outcome and economic data. However there is an expectation that a majority of oncology providers (60%) will have developed such capabilities within the next 2 years.
authors.affiliation: Cancer Center Business Development Group, Bedford, NH; Reimbursement Intelligence, Madison, NJ.
authors.forename: Ronald
authors.initials: R
authors.lastname: Barkley
authors.forename: Rhonda
authors.initials: R
authors.lastname: Greenapple
authors.forename: John
authors.initials: J
authors.lastname: Whang
mesh_terms: D006801:Humans; D008495:Medical Oncology / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data; D013223:Statistics as Topic